SCHEMBL25848282

SCHEMBL25848282

C=CC(=O)OC1CCC(Oc2ccc3cc(-c4ccc(CCCCC)cc4C)c(=O)oc3c2)C1(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 3/20 0.40
MAOB P27338 6/20 0.36
MAOA P21397 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.34
TP53 P04637 1/20 0.34
S1PR1 P21453 1/20 0.33
S1PR3 Q99500 1/20 0.33
NPC1 O15118 5/20 0.33
RAB9A P51151 5/20 0.33
KDM4E B2RXH2 3/20 0.33
GLA P06280 3/20 0.33
ALDH1A1 P00352 2/20 0.33
GAA P10253 2/20 0.33
HPGD P15428 2/20 0.33
MAPT P10636 1/20 0.33
PKM P14618 1/20 0.33
MAPK1 P28482 1/20 0.33
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MEN1 O00255 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25848279 0.93 THRB (0.41) THRBMAOBMAOASMN1; SMN2S1PR1
SCHEMBL25848291 0.92 THRB (0.39) THRBMAOBMAOAS1PR1NPC1
SCHEMBL25848285 0.90 MAOB (0.36) THRBMAOBMAOASMN1; SMN2TP53
SCHEMBL25848288 0.89 THRB (0.37) THRBMAOBMAOASMN1; SMN2S1PR1
SCHEMBL25848295 0.86 RAB9A (0.41) MAOBMAOASMN1; SMN2TP53NPC1
SCHEMBL25848257 0.86 THRB (0.41) THRBMAOBMAOASMN1; SMN2TP53
SCHEMBL21735061 0.84 S1PR1 (0.43) THRBMAOBS1PR1S1PR3
SCHEMBL22625315 0.84 THRB (0.38) THRBMAOBMAOASMN1; SMN2S1PR1
SCHEMBL22625162 0.83 THRB (0.37) THRBMAOBMAOASMN1; SMN2S1PR1
SCHEMBL22624982 0.83 THRB (0.37) THRBMAOBMAOASMN1; SMN2S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11702396-B2 Hydrophobic compounds for optically active devices Johnson & Johnson Surgical Vision, Inc. (US) 2023-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11702396-B2 Hydrophobic compounds for optically active devices UACA, CRYZ, TRPA1 THRB 3289/4885MAOB 3207/4885MAOA 2922/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.